Should drug labels have comparative effectiveness info?; Armey forced out of drug lobbying job;

> The New England Journal of Medicine is arguing that drug labels ought to include information on how meds compare with other treatments for the same conditions--possibly under the authority of the FDA. FiercePharma

> Former House Republican Leader Dick Armey was forced to quit his high-profile lobbying job when drug company clients complained about his off-the-clock opposition to healthcare reform. FiercePharma

>
Shareholders of Allscripts-Misys Healthcare Solutions have sued the ambulatory EMR vendor after its CEO, perhaps a bit foolishly, said that the company may have rushed version 11 of its flagship product to market. FierceEMR

And Finally... If you don't want your money, there's probably safer ways to get rid of it. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.